Abstract:BACKGROUND:Lung function measures reflect the physiological state of the lung, and are essential to the diagnosis of chronic obstructive pulmonary disease (COPD). The SpiroMeta-CHARGE consortium undertook the largest genome-wide association study (GWAS) so far (n=48,201) for forced expiratory volume in 1 s (FEV1) and the ratio of FEV1 to forced vital capacity (FEV1/FVC) in the general population. The lung expression quantitative trait loci (eQTLs) study mapped the genetic architecture of gene expression in lung tissue from 1111 individuals. We used a systems genetics approach to identify single nucleotide polymorphisms (SNPs) associated with lung function that act as eQTLs and change the level of expression of their target genes in lung tissue; termed eSNPs. METHODS:The SpiroMeta-CHARGE GWAS results were integrated with lung eQTLs to map eSNPs and the genes and pathways underlying the associations in lung tissue. For comparison, a similar analysis was done in peripheral blood. The lung mRNA expression levels of the eSNP-regulated genes were tested for associations with lung function measures in 727 individuals. Additional analyses identified the pleiotropic effects of eSNPs from the published GWAS catalogue, and mapped enrichment in regulatory regions from the ENCODE project. Finally, the Connectivity Map database was used to identify potential therapeutics in silico that could reverse the COPD lung tissue gene signature. FINDINGS:SNPs associated with lung function measures were more likely to be eQTLs and vice versa. The integration mapped the specific genes underlying the GWAS signals in lung tissue. The eSNP-regulated genes were enriched for developmental and inflammatory pathways; by comparison, SNPs associated with lung function that were eQTLs in blood, but not in lung, were only involved in inflammatory pathways. Lung function eSNPs were enriched for regulatory elements and were over-represented among genes showing differential expression during fetal lung development. An mRNA gene expression signature for COPD was identified in lung tissue and compared with the Connectivity Map. This in-silico drug repurposing approach suggested several compounds that reverse the COPD gene expression signature, including a nicotine receptor antagonist. These findings represent novel therapeutic pathways for COPD. INTERPRETATION:The system genetics approach identified lung tissue genes driving the variation in lung function and susceptibility to COPD. The identification of these genes and the pathways in which they are enriched is essential to understand the pathophysiology of airway obstruction and to identify novel therapeutic targets and biomarkers for COPD, including drugs that reverse the COPD gene signature in silico. FUNDING:The research reported in this article was not specifically funded by any agency. See Acknowledgments for a full list of funders of the lung eQTL study and the Spiro-Meta CHARGE GWAS.

Genetic susceptibility to pneumonia: A GWAS meta-analysis between UK Biobank and FinnGen

Association of IL-10 (-819T/C, -592A/C and -1082A/G) and IL-6 -174G/C Gene Polymorphism and the Risk of Pneumonia-Induced Sepsis

Exploring genetic risk factors for pneumonia using biobank resources - Insights across subpopulations

Genome-wide association study of susceptibility to hospitalised respiratory infections

A genome-wide association study of adults with community-acquired pneumonia

Genetic variants associated with severe pneumonia in A/H1N1 influenza infection.

Associations of Three Well-Characterized Polymorphisms in the IL-6 and IL-10 Genes with Pneumonia: A Meta-Analysis

Selection Signature Reveals Genes Associated with Susceptibility Loci Affecting Respiratory Disease Due to Pleiotropic and Hitchhiking Effect in Chinese Indigenous Pigs

Genome-wide Association Studies for Identifying Genetic Architecture of SGRQ in Smoking Population

The Causal Relationship Between Rheumatoid Arthritis and Pneumonia: A Mendelian Randomization Study

A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci

Genetic Variants Associated with Chronic Obstructive Pulmonary Disease Risk: Cumulative Epidemiological Evidence from Meta-Analyses and Genome-Wide Association Studies

Genome-wide Interaction Study of Gene-by-occupational Exposures on Respiratory Symptoms.

A genome-wide association study of asthma hospitalizations in adults

Molecular mechanisms underlying variations in lung function: a systems genetics analysis

Genome-wide Association Study of Susceptibility to Pseudomonas Aeruginosa Infection in Cystic Fibrosis.

Human genetic associations of the airway microbiome in chronic obstructive pulmonary disease

Respiratory traits and coal workers’ pneumoconiosis: Mendelian randomisation and association analysis

Polymorphism of genes associated with infectious lung diseases in Northern Asian populations and in patients with community-acquired pneumonia

Periodontitis and Chronic Obstructive Pulmonary Disease: A bidirectional Mendelian randomization study